All Articles

Understanding the basics of what cancer care involves is foundational for oncology patient navigators. In the second installment of Navigation Refresh, we dive into the continuum of cancer care, cancer risk factors, detection, diagnosis, and treatment.

The CATCH: In Support of Ensuring Appropriate Imaging Before Treatment Planning

The CATCH

April 2025 Vol 16, No 4

A CATCH is a navigation success story where a navigation tactic improved a patient’s situation. This month, we profile the experience of a navigator who coordinated staging scans for her patient to ensure they were completed the day before the patient had her oncology consultation.

Navigators Can Impact a Patient’s Perception of Biosimilars

By Sharon S. Gentry, MSN, RN, HON-ONN-CG, AOCN, CBCN

The Editor’s Take

March 2025 Vol 16, No 3

It is important that all navigators fully understand biosimilars so that they can address the “nocebo” effect and help implement strategies to optimize their use, ensuring that patients receive cost-effective treatment without compromising quality of care.

A Word From the Father of Patient Navigation, Harold P. Freeman, MD

By Harold P. Freeman, MD

The Director's Cut

March 2025 Vol 16, No 3

An exciting new chapter begins for JONS as we welcome Harold P. Freeman, MD, to our Board as Editor Emeritus.

Beyond the Jargon: Explaining Biosimilars to Patients

By Sharon S. Gentry, MSN, RN, HON-ONN-CG, AOCN, CBCN

Biosimilars

March 2025 Vol 16, No 3

As biosimilars increase in the care arena of cancer treatment, it is critical that patients be informed of this classification of treatment in a way that allows for shared decision-making.

Navigation Refresh: Revisions to GW Oncology Patient Navigation Training Improve Standards to Meet PIN Reimbursement Requirements

By Mandi L. Pratt-Chapman, PhD, MA, HON-OPN-CG

Navigation

March 2025 Vol 16, No 3

In this debut of a JONS regular feature focused on keeping oncology navigators at the forefront of their field, Mandi L. Pratt-Chapman, PhD, MA, HON-OPN-CG, explores recent revisions to the George Washington Cancer Center’s Oncology Patient Navigator Training program.

Evaluating the Effectiveness of the National Oncology Navigation Acuity Tool: Insights From a Multisite Quality Initiative

By Danelle Johnston, MSN, RN, OCN, ONN-CG; Tricia Strusowski, MS, RN

Original Research

March 2025 Vol 16, No 3

Researchers who evaluated the versatility and efficacy of the National Oncology Navigation Acuity Tool share their findings and suggest that the tool could become an essential asset in streamlining oncology care and maximizing the effectiveness of patient navigation services.

Billing for Navigation Services

Reimbursement

March 2025 Vol 16, No 3

The significance of billing for navigation services remains a hot topic of discussion.

Reflections: Findings and Insights From the 2024 AONN+ Survey

By Sharon S. Gentry, MSN, RN, HON-ONN-CG, AOCN, CBCN

Highlights From AONN+

March 2025 Vol 16, No 3

The Academy of Oncology Nurse & Patient Navigators (AONN+) is continuously working to listen to its membership, and one avenue is through a biennial membership survey. Here we present findings and insights from the 2024 AONN+ survey.

Identification and Treatment of Patients With Hormone Receptor–Positive, HER2-Negative Early Breast Cancer at High Risk of Recurrence: monarchE Study Long-Term Outcomes

Clinical Trials, HR+/HER2− Breast Cancer, Breast Cancer

Special Issues and Supplements

We are pleased to announce the release of our next issue of Clinical Trials to Clinical Practice. This article provides expert commentary from Joyce A. O’Shaughnessy, MD, on the use of endocrine therapy with or without adjuvant abemaciclib for patients with high-risk, hormone receptor (HR)-positive, HER2-negative early breast cancer.

All Articles

Page 11 of 281

Connect with Us

Subscribe Today!

I'd like to receive:

Please enter your mailing address.